Pharmacology

Trials, guidelines and clinical evidence across Pharmacology.

Methocarbamol label warns of CNS depression, pregnancy risk, and overdose

DailyMed updates for methocarbamol detail CNS depression, pregnancy cautions, renal and hepatic handling, overdose risks, and dosing guidance.

By Dr. A. Nikhil Krishnan, MBBS · Oct 21, 2026 · 5 min read

Pharmacology·DailyMed

Cold and Sinus Relief label lists ibuprofen 200 mg with pseudoephedrine 30 mg

DailyMed label details an OTC ibuprofen-pseudoephedrine capsule for cold and sinus symptoms, with NSAID, cardiovascular, and pregnancy warnings.

Oct 21, 2026

Pharmacology·PNAS

Concise Guide to Pharmacology 2025/26 Updates GPCR Target Reference

The 2025/26 Concise Guide to Pharmacology catalogs GPCR nomenclature, curated tools, and nearly 1,900 human drug targets in…

Oct 21, 2026

Pharmacology·BMJ Open

Benzodiazepines and Macrolides: Injury Risk Compared With Clarithromycin vs Azithromycin

US Medicaid cohort study compared injury risk in benzodiazepine users receiving clarithromycin versus azithromycin, focusing on interaction-prone prescribing.

Oct 20, 2026

Pharmacology·ACC-PRO

Lilly Signs $1.1B Metis Deal for AI Lipid Nanoparticle Discovery

Eli Lilly struck a $1.1 billion partnership with Metis TechBio to advance AI-guided lipid nanoparticle discovery for drug…

Oct 20, 2026

Pharmacology·STAT

FDA forms exclusivity board to tighten drug approval decisions

FDA has formed a board to review exclusivity decisions, aiming to bring more consistency to five-year and three-year…

Oct 20, 2026

Pharmacology·ACC-PRO

Drug Discovery Must Start With Patient Benefit, IQVIA Says

IQVIA Laboratories argues that discovery decisions should be anchored in human biology, biomarkers and patient selection before trials…

Oct 20, 2026

Pharmacology·DailyMed

Cold and Cough OTC label lists brompheniramine, dextromethorphan, phenylephrine

DailyMed label update for an OTC cold and cough solution details active ingredients, dosing limits, age cutoffs, warnings,…

Oct 19, 2026

Pharmacology·EMA

Generic long-acting injectable availability lags behind regulatory standards

FDA and European regulators differ in long-acting injectable approvals and bioequivalence guidance, shaping access to generic LAI therapies.

Oct 19, 2026

Pharmacology·STAT

Isomorphic Labs and the test of AI-driven drugmaking

Isomorphic Labs wants to convert its technology into a medicine engine, but its real test is whether it…

Oct 19, 2026

Pharmacology

Trials, guidelines and clinical evidence across Pharmacology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.